Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Identification of Inflammatory Neuronal Injury and Prevention of Neuronal Damage in Multiple Sclerosis: Hope for Novel Therapies?
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
Microglia as a critical player in both developmental and late-life CNS pathologies.
Risk factors for increased multiple sclerosis susceptibility in the Iranian population.
Pilot Trial of a Social Cognitive Theory-Based Physical Activity Intervention Delivered by Non-Supervised Technology in Persons With Multiple Sclerosis.
Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design.
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders.
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
The role of speed versus working memory in predicting learning new information in multiple sclerosis.
Timing of cigarette smoking as a risk factor for multiple sclerosis.
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
Sleep disturbances in patients with multiple sclerosis.
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
People with Multiple Sclerosis use many fall prevention strategies but still fall frequently.

Pages